Document Detail

Effect of cow's milk exposure and maternal type 1 diabetes on cellular and humoral immunization to dietary insulin in infants at genetic risk for type 1 diabetes. Finnish Trial to Reduce IDDM in the Genetically at Risk Study Group.
MedLine Citation:
PMID:  11016449     Owner:  NLM     Status:  MEDLINE    
Type 1 diabetes is considered to be a T-cell-mediated autoimmune disease in which insulin-producing beta-cells are destroyed. Immunity to insulin has been suggested to be one of the primary autoimmune mechanisms leading to islet cell destruction. We have previously shown that the first immunization to insulin occurs by exposure to bovine insulin (BI) in cow's milk (CM) formula. In this study, we analyzed the development of insulin-specific T-cell responses by proliferation test, emergence of insulin-binding antibodies by enzyme immunoassay, and insulin autoantibodies by radioimmunoassay in relation to CM exposure and family history of type 1 diabetes in infants with a first-degree relative with type 1 diabetes and increased genetic risk for the disease. The infants were randomized to receive either an adapted CM-based formula or a hydrolyzed casein (HC)-based formula after breast-feeding for the first 6-8 months of life. At the age of 3 months, both cellular and humoral responses to BI were higher in infants exposed to CM formula than in infants fully breast-fed (P = 0.015 and P = 0.007). IgG antibodies to BI were higher in infants who received CM formula than in infants who received HC formula at 3 months of age (P = 0.01), but no difference in T-cell responses was seen between the groups. T-cell responses to BI at 9 months of age (P = 0.05) and to human insulin at 12 (P = 0.014) and 24 months of age (P = 0.009) as well as IgG antibodies to BI at 24 months of age (P = 0.05) were lower in children with a diabetic mother than in children with a diabetic father or a sibling, suggesting possible tolerization to insulin by maternal insulin therapy. The priming of insulin-specific humoral and T-cell immunity occurs in early infancy by dietary insulin, and this phenomenon is influenced by maternal type 1 diabetes.
J Paronen; M Knip; E Savilahti; S M Virtanen; J Ilonen; H K Akerblom; O Vaarala
Related Documents :
18411119 - Antibody markers for type 1 diabetes: the issues.
10724349 - Immunologically-related or incidental coexistence of diabetes mellitus and graves' dise...
9453289 - Viruses and other perinatal exposures as initiating events for beta-cell destruction.
21515849 - Association of genetic loci with glucose levels in childhood and adolescence: a meta-an...
23109389 - Magnetic labeling of pancreatic β-cells modulates the glucose- and insulin-induced pho...
21297519 - A critical appraisal of vlasselaers d, milants i, desmet l, wouters pj, vanhorebeek i, ...
3530929 - Intravenous glucose tolerance after whipple's procedure in patients with chronic pancre...
24471559 - The transcultural diabetes nutrition algorithm toolkit: survey and content validation i...
23037459 - Risk for future diabetes among individuals with high-normal glycemia at 40 years of age.
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Diabetes     Volume:  49     ISSN:  0012-1797     ISO Abbreviation:  Diabetes     Publication Date:  2000 Oct 
Date Detail:
Created Date:  2000-10-17     Completed Date:  2000-10-17     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0372763     Medline TA:  Diabetes     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1657-65     Citation Subset:  AIM; IM    
Hospital for Children and Adolescents, University of Helsinki, Finland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antibody Formation
Autoantibodies / blood
Diabetes Mellitus, Type 1 / genetics,  immunology*
Genetic Predisposition to Disease*
Immunity, Cellular
Immunoenzyme Techniques
Infant Food
Insulin / administration & dosage,  immunology*
T-Lymphocytes / immunology
Reg. No./Substance:
0/Autoantibodies; 0/Caseins; 11061-68-0/Insulin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  5-aminoimidazole-4-carboxamide ribonucleoside (AICAR) inhibits insulin-stimulated glucose transport ...
Next Document:  Anti-CD154 (CD40L) prevents recurrence of diabetes in islet isografts in the DR-BB rat.